These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12819488)

  • 1. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity.
    Coates PT; Colvin BL; Kaneko K; Taner T; Thomson AW
    Transplantation; 2003 May; 75(9 Suppl):32S-36S. PubMed ID: 12819488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.
    Turnquist HR; Fischer RT; Thomson AW
    Methods Mol Biol; 2010; 595():135-48. PubMed ID: 19941109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
    Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
    Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of tolerogenic dendritic cells for transplantation.
    Morelli AE; Hackstein H; Thomson AW
    Semin Immunol; 2001 Oct; 13(5):323-35. PubMed ID: 11502167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation.
    Abe M; Metes D; Thomson AW
    Expert Rev Clin Immunol; 2005 Sep; 1(3):419-30. PubMed ID: 20476992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
    Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
    Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory dendritic cell therapy in organ transplantation.
    McCurry KR; Colvin BL; Zahorchak AF; Thomson AW
    Transpl Int; 2006 Jul; 19(7):525-38. PubMed ID: 16764631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy.
    Lo J; Clare-Salzler MJ
    Autoimmun Rev; 2006 Jul; 5(6):419-23. PubMed ID: 16890897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing dendritic cells for the induction of transplantation tolerance.
    Silk KM; Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):344-50. PubMed ID: 19417656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells in transplant tolerance.
    Nouri-Shirazi M
    Iran J Immunol; 2007 Mar; 4(1):1-14. PubMed ID: 17652838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of immunosuppressive drugs on dendritic cells and tolerance induction.
    Lagaraine C; Lebranchu Y
    Transplantation; 2003 May; 75(9 Suppl):37S-42S. PubMed ID: 12819489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fashioning regulatory dendritic cells: what is currently in vogue?
    Taner T; Thomson AW
    Curr Opin Mol Ther; 2004 Feb; 6(1):78-82. PubMed ID: 15011784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
    Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
    J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.